- Ribbon Bio brings deep expertise in synthetic DNA, supporting the development of faster and more reproducible mRNA therapies. Their proprietary MiroSynth™ DNA technology delivers high-fidelity, long, IVT-ready linear DNA templates with over 90% sequence accuracy, eliminating the need for plasmid linearization and purification.
- Ribbon’s algorithm-driven synthetic DNA assembly process ensures end-to-end traceability, making it well suited for preclinical and translational workflows. This also enables direct integration into manufacturing processes for next-generation therapies, allowing for a seamless chain of control.
- Ribbon’s model is not only to provide custom, synthetic DNA to the biopharma industry, but also to form strategic partnerships that drive innovators to move beyond the limits of current synthetic manufacturing capabilities.
- Ribbon’s membership reflects a shared commitment to building scalable, accessible solutions for health and precision medicine.